July 6, 2007 (updated September 11, 2007) — The safety labeling for ceftriaxone sodium injection ( Rocephin; Roche Pharmaceuticals, Inc) has been updated to describe the potential risks associated ...
May 28, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise of potential decreases in bone mineral density in patients receiving long-term treatment with ...
(WHNT) — The Alabama Department of Public Health issued a statement Wednesday about its current investigation into certain “adverse events” following an injection. In the news release, ADPH said it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results